Skip to main content

Pharmaceutical News and Articles

Comprehensive and up-to-date drug news for both consumers and healthcare professionals.

Cases of Drug-Resistant Gonorrhea Have Tripled in China, Posing a Global Threat

THURSDAY, March 28, 2024 -- A strain of highly antibiotic-resistant gonorrhea first emerged in China in 2016, and cases of this tough-to-treat infection have...

Doctor Gets First U.S. Lung-Liver Transplant for Advanced Lung Cancer

THURSDAY, March 28, 2024 -- Dr. Gary Gibbon didn’t have long to live. A harsh cocktail of chemotherapy, radiation and immunotherapy for his advanced...

An ED-Based Smoking Cessation Intervention Is Feasible, Effective

THURSDAY, March 28, 2024 -- A brief opportunistic intervention to support sustained tobacco smoking abstinence in the emergency department is feasible and...

Inorganic Nitrate Treatment Cuts Rate of Contrast-Induced Nephropathy

THURSDAY, March 28, 2024 -- For patients presenting with acute coronary syndromes (ACS) undergoing coronary angiography, inorganic nitrate treatment reduces...

Stepped Collaborative Intervention Improves Quality of Life in Cancer

THURSDAY, March 28, 2024 -- A stepped collaborative care intervention can improve health-related quality of life for patients with cancer and depression, pain...

Nerve Decompression May Ease Painful Diabetic Peripheral Neuropathy

THURSDAY, March 28, 2024 -- For patients with lower-extremity painful diabetic peripheral neuropathy (DPN), nerve decompression is associated with reduced...

Improvements Seen in Post-Allo-HCT Outcomes for Seniors With Leukemia

THURSDAY, March 28, 2024 -- For older patients with acute myeloid leukemia (AML) undergoing allogeneic hematopoietic cell transplantation (allo-HCT)...

Good Sleep Can Make You Feel Young

THURSDAY, March 28, 2024 -- A good night’s sleep can make you feel years younger, while crummy sleep leaves you doddering around like an oldster, a new...

Binge Drinking Boosts Heart Risks, Especially for Women

THURSDAY, March 28, 2024 -- Imbibing more than a drink per day significantly raises heart risks for all, but binge drinking is especially harmful, particularly...

Too Often, Nearby Defibrillators Go Unused on People in Cardiac Arrest

THURSDAY, March 28, 2024 -- There's been a big push over the past few years to get automated external defibrillators (AEDs) installed in public spaces, to help...

FDA Approves Winrevair (sotatercept-csrk) a First-in-Class Treatment for Adults with Pulmonary Arterial Hypertension

RAHWAY, N.J.--(BUSINESS WIRE) March 26, 2024 -- Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today that the U.S. Food...

FDA Approves Medexus's Supplemental Biologics License Application for Ixinity to Treat Hemophilia B in Pediatric Patients

Toronto, Ontario and Chicago, Illinois-- March 26, 2024 - Medexus Pharmaceuticals (TSX: MDP) (OTCQX: MEDXF) today announced that the US Food and Drug...

Ultomiris Approved in the US for the Treatment of Adults with Neuromyelitis Optica Spectrum Disorder (NMOSD)

25 March 2024 -- Ultomiris (ravulizumab-cwvz) has been approved in the United States (US) as the first and only long-acting C5 complement inhibitor for the...

Regeneron Provides Update on Biologics License Application for Odronextamab

TARRYTOWN, N.Y., March 25, 2024 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the U.S. Food and Drug Administration...

FDA Approves Duvyzat (givinostat) for Duchenne Muscular Dystrophy

MILAN--(BUSINESS WIRE)-- Mar 22, 2024 -- Italfarmaco S.p.A. announced today that the U.S. Food and Drug Administration (FDA) has approved Duvyzat&trade...

FDA Approves Opsynvi (macitentan and tadalafil) for Adults with Pulmonary Arterial Hypertension

RARITAN, NJ, March 22, 2024 – Johnson & Johnson today announced that the U.S. Food and Drug Administration (FDA) has approved Opsynvi® – a...

Journey Medical Corporation Announces U.S. FDA Acceptance of New Drug Application for DFD-29 for the Treatment of Rosacea

SCOTTSDALE, Ariz., March 18, 2024 (GLOBE NEWSWIRE) -- Journey Medical Corporation (Nasdaq: DERM) (“Journey Medical” or “the Company”)...

U.S. Food and Drug Administration (FDA) Has Accepted the New Drug Application (NDA) for Ensartinib

MIAMI--(BUSINESS WIRE) March 13, 2024 --Xcovery Holdings, Inc., an oncology focused pharmaceutical company, today announced that the U.S. Food and Drug...

Lumicell Announces FDA Advisory Committee’s Positive Recommendation on the Benefit-Risk Profile of Lumisight in the Detection of Cancerous Tissue During Breast Conserving Surgery

NEWTON, Massachusetts March 6, 2024 – Lumicell, Inc., a privately held company focused on innovative fluorescence-guided imaging technologies for cancer...

SpringWorks Therapeutics Initiates Rolling Submission of New Drug Application to the FDA for Mirdametinib for the Treatment of Children and Adults with NF1-PN

STAMFORD, Conn., March 04, 2024 (GLOBE NEWSWIRE) -- SpringWorks Therapeutics, Inc. (Nasdaq: SWTX), a commercial-stage biopharmaceutical company focused on...

Johnson & Johnson's Nipocalimab Granted U.S. FDA Fast Track Designation to Reduce the Risk of Fetal Neonatal Alloimmune Thrombocytopenia (FNAIT) in Alloimmunized Pregnant Adults

SPRING HOUSE, Pa. March 26, 2024 – Johnson & Johnson announced today that the U.S. Food and Drug Administration (FDA) has granted Fast Track...

Tonix Pharmaceuticals Receives Rare Pediatric Disease Designation from the FDA for TNX-2900 for the Treatment of Prader-Willi Syndrome

CHATHAM, N.J., March 25, 2024 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a biopharmaceutical company with...

Invivyd Announces FDA Authorization for Emergency Use of Pemgarda (Formerly VYD222) for Pre-Exposure Prophylaxis (PrEP) of COVID-19

WALTHAM, Mass., March 22, 2024 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Nasdaq: IVVD), a biopharmaceutical company on a mission to protect the vulnerable from...

Lisata Therapeutics Announces U.S. FDA Rare Pediatric Disease Designation Granted to LSTA1 for the Treatment of Osteosarcoma

BASKING RIDGE, N.J., March 21, 2024. Lisata Therapeutics, Inc. (“Lisata” or the “Company”), a clinical-stage pharmaceutical company...

HI-Bio Receives FDA Orphan Drug Designation for Felzartamab for the Treatment of Antibody-Mediated Rejection (AMR) in Kidney Transplant Recipients

SOUTH SAN FRANCISCO, Calif., – March 21, 2024 – Human Immunology Biosciences (HI-Bio™), a clinical-stage biotechnology company developing...

Browse by news type

Drugs.com Newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.

Disclaimer

This library contains syndicated news articles. These articles have not been peer-reviewed by Drugs.com, and therefore we cannot guarantee accuracy to the highest ethical standards. Do further research as needed. Consultation with your physician is essential.